LoadingLoadingLoadingThe quick read
Latest quote·Oct 16
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Dover Corporation (DOV) insiders filed no open-market purchases or sales in the 90 days to Oct 18, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a DOV trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position.
Buys/Adds (2)
Schonfeld
$68.1M
bought
Point72
$58.2M
bought
Sells/Trims (1)
Qube Research
$39.8M
trimmed
No tracked top-trader positions in DOV right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 23, 2026
Financial period
Q2 2026
Earnings per share
$2.72 expected
Revenue
No comparable estimate
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 23, 2026 | $2.74 / $2.72Alpha Vantage | +0.74% in line | $2.19B / Unavailable | Unavailable |
| Mar 31, 2026 | Apr 23, 2026 | $2.28 / $2.27Alpha Vantage | +0.44% in line | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 29, 2026 | $2.51 / $2.49Alpha Vantage | +0.80% in line | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 23, 2025 | $2.62 / $2.51Alpha Vantage | +4.38% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 24, 2025 | $2.44 / $2.39Alpha Vantage | +2.09% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 24, 2025 | $2.05 / $1.98Alpha Vantage | +3.54% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Jan 30, 2025 | $2.20 / $2.08Alpha Vantage | +5.77% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 24, 2024 | $2.27 / $2.18Alpha Vantage | +4.13% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$2.77 to $2.91
Revenue expected
14 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.08B | $2.10B | $2.05B | $2.19B |
| Cost of what it sold | $1.24B | $1.28B | $1.26B | $1.31B |
| Gross profit | $833.6M | $820.8M | $798.1M | $880.6M |
| What it spent | ||||
| Research and development | $43.5M | — | — | — |
| Sales and admin | $456.4M | $475.5M | $492.2M | $488.8M |
| Other operating costs | -$43.5M | — | — | — |
| Total operating expenses | $456.4M | $475.5M | $492.2M | $488.8M |
| What was left | ||||
| Operating profit | $377.2M | $345.3M | $305.9M | $391.8M |
| Interest on debt | $27.2M | $28.1M | $29.5M | $29.1M |
| Profit before tax | $386.2M | $340.5M | $298.9M | $387.7M |
| Tax | $83.0M | $65.8M | $60.2M | $75.2M |
| Net profit | $302.0M | $282.1M | $238.4M | $312.2M |
| EBITDA | $511.9M | $468.0M | $425.8M | $391.8M |
This stock is trending upward.
Trend
Constructive
75 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
